Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment
Drug Design, Development and Therapy · 2024-09 · Volume 18 · 4089-4116
DOI: 10.2147/dddt.s469331 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-09. Verfasst von Feiyu Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221004, People's Republic of China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cardiotoxicity. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221004, People's Republic of China.
Zitieren
APA
Gao, F., Xu, T., Zang, F., Luo, Y., & Pan, D. (2024). Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment. Drug Design, Development and Therapy, Volume 18, 4089-4116. https://doi.org/10.2147/dddt.s469331
Vancouver
Gao F, Xu T, Zang F, Luo Y, Pan D. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment. Drug Design, Development and Therapy. 2024;Volume 18:4089-4116. doi:10.2147/dddt.s469331
BibTeX
@article{Gao2024,
author = {Gao, Feiyu and Xu, Tao and Zang, Fangnan and Luo, Yuanyuan and Pan, Defeng},
title = {Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment},
journal = {Drug Design, Development and Therapy},
year = {2024},
volume = {Volume 18},
pages = {4089--4116},
doi = {10.2147/dddt.s469331}
}
EUVIMED